Pages that link to "Item:Q7"

← Segment (Q7)

What links here

Page:  Namespace:  all (Main) Talk User User talk Wikibase.slis.ua.edu Wikibase.slis.ua.edu talk File File talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Item Item talk Property Property talk Module Module talk   Invert selection

Filters

Hide transclusions | Hide links | Hide redirects

The following pages link to Segment (Q7):

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

• JK Scott kickoff for 65 yds for a touchback (Q232) ‎ (← links)
• Jake Fromm pass complete to Nick Chubb for a loss of 1 yard to the Geo 24 (Q233) ‎ (← links)
• Jake Fromm pass complete to Terry Godwin for 4 yds to the Geo 28 (Q234) ‎ (← links)
• Jake Fromm pass intercepted Tony Brown return for no gain to the Alab 36 (Q235) ‎ (← links)
• Damien Harris run for 4 yds to the Alab 40 (Q236) ‎ (← links)
• Jalen Hurts pass complete to Robert Foster for 8 yds to the Alab 48 for a 1ST down (Q237) ‎ (← links)
• Sample Play (Q241) ‎ (← links)
• Sample Play3 (Q242) ‎ (← links)
• Sample Play4 (Q243) ‎ (← links)
• Sample Play5 (Q244) ‎ (← links)
• Sample Play6 (Q245) ‎ (← links)
• Sample Play7 (Q246) ‎ (← links)
• Sample Play8 (Q247) ‎ (← links)
• Sample Play9 (Q248) ‎ (← links)
• Sample Play10 (Q249) ‎ (← links)
• Demo Play (Q279) ‎ (← links)
• Introduction section from DOI: 10.3390/pathogens9020148 (Q7903) ‎ (← links)
• Novel Coronavirus 2019-nCoV section from DOI: 10.3390/pathogens9020148 (Q7904) ‎ (← links)
• Transmission and Symptoms section from DOI: 10.3390/pathogens9020148 (Q7905) ‎ (← links)
• Perspectives on Biopharmaceuticals Development section from DOI: 10.3390/pathogens9020148 (Q7906) ‎ (← links)
• Concluding Remarks section from DOI: 10.3390/pathogens9020148 (Q7907) ‎ (← links)
• Introduction (Main section from DOI: 10.7326/m20-0504) (Q7922) ‎ (← links)
• Methods: Data Collection (Subsection from DOI: 10.7326/m20-0504) (Q7923) ‎ (← links)
• Methods: Statistical Analysis (Subsection from DOI: 10.7326/m20-0504) (Q7924) ‎ (← links)
• Methods: Role of the Funding Source (Subsection from DOI: 10.7326/m20-0504) (Q7925) ‎ (← links)
• Results (Main section from DOI: 10.7326/m20-0504) (Q7926) ‎ (← links)
• Discussion (Main section from DOI: 10.7326/m20-0504) (Q7927) ‎ (← links)
• Introduction (Section from DOI: 10.1080/09273948.2020.1738501) (Q8063) ‎ (← links)
• The Coronavirus Structure and Host (Section from DOI: 10.1080/09273948.2020.1738501) (Q8064) ‎ (← links)
• Human Coronaviruses and the Evidence for Ocular Manifestations (Section from DOI: 10.1080/09273948.2020.1738501) (Q8065) ‎ (← links)
• Feline Coronaviruses and Ocular Manifestations (Section from DOI: 10.1080/09273948.2020.1738501) (Q8066) ‎ (← links)
• Mouse Coronaviruses and Ocular Implications (Section from DOI: 10.1080/09273948.2020.1738501) (Q8067) ‎ (← links)
• Conclusion (Section from DOI: 10.1080/09273948.2020.1738501) (Q8068) ‎ (← links)
• Introduction section from DOI: 10.1186/s13613-020-00653-z (Q8290) ‎ (← links)
• Methods section from DOI: 10.1186/s13613-020-00653-z (Q8291) ‎ (← links)
• Results section from DOI: 10.1186/s13613-020-00653-z (Q8292) ‎ (← links)
• Discussion section from DOI: 10.1186/s13613-020-00653-z (Q8293) ‎ (← links)
• Conclusions section from DOI: 10.1186/s13613-020-00653-z (Q8294) ‎ (← links)
• Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265) (Q8394) ‎ (← links)
• Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8395) ‎ (← links)
• Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8396) ‎ (← links)
• Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) (Q8397) ‎ (← links)
• Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) (Q8398) ‎ (← links)
• Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) (Q8399) ‎ (← links)
• Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8400) ‎ (← links)
• Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8401) ‎ (← links)
• Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) (Q8402) ‎ (← links)
• Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) (Q8403) ‎ (← links)
• Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) (Q8404) ‎ (← links)
• Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) (Q8405) ‎ (← links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)